The stock of CARGO Therapeutics Inc (NASDAQ:CRGX) last traded at $4.6, up 0.44% from the previous session.
CRGX stock price is now 7.30% away from the 50-day moving average and -54.38% away from the 200-day moving average. The market capitalization of the company currently stands at $212.12M.
On January 30, 2025, Truist Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock reducing its target price from $32 to quote $7, while ‘Piper Sandler’ rates the stock as ‘Neutral’
In other news, Radhakrishnan Anup, insider sold 1,632 shares of the company’s stock on Jul 02 ’25. The stock was sold for $6,822 at an average price of $4.18. Upon completion of the transaction, the insider now directly owns 120,781 shares in the company, valued at $0.56 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 14 ’25, Radhakrishnan Anup sold 27,404 shares of the business’s stock. A total of $105,272 was realized by selling the stock at an average price of $3.84. This leaves the insider owning 122,413 shares of the company worth $0.56 million. A total of 28.76% of the company’s stock is owned by insiders.
During the past 12 months, CARGO Therapeutics Inc has had a low of $3.00 and a high of $25.45. As of last week, the company has a debt-to-equity ratio of 0.11, a current ratio of 6.30, and a quick ratio of 6.30. The fifty day moving average price for CRGX is $4.2872 and a two-hundred day moving average price translates $10.0841 for the stock.
The latest earnings results from CARGO Therapeutics Inc (NASDAQ: CRGX) was released for 2025-03-31.
